journal article·2020-11-24

Few-Layer Bismuthene for Checkpoint Knockdown Enhanced Cancer Immunotherapy with Rapid Clearance and Sequentially Triggered One-for-All Strategy

Mengyu Guo, Xiao Zhang, Jing Liu, Fene Gao, Xiaolei Zhang, Xuhao Hu, Bo Li, Xu Zhang, Huige Zhou, Ru Bai, Yaling Wang, Jiayang Li, Ying Liu, Zhanjun Gu, Chunying Chen

ACS Nano· Volume 14· Issue 11
Publisher page

Abstract

As a conceptually attractive strategy, the use of immune checkpoint blockade antibodies to treat cancer is limited due to the restrained tumor-infiltrating lymphocytes (TILs), poor accumulation and penetration of antibodies, and deficient checkpoint blockade in malignancies. In this study, we describe a pH and mild photothermal sequentially triggered PD-L1 siRNA release nanosystem, based on monoelemental bismuthene, as a one-for-all strategy to realize enhanced tumor mild photothermal immunotherapy. Under manually controlled NIR irradiation, the bismuthene-based nanosystem simultaneously induces a tumor-enhanced pathological permeability and retention (EPPR) effect, increases TIL recruitment, and triggers programmed siRNA release, thereby amplifying anti-PD-L1 immunotherapy. In addition, the nanosystem’s rapid removal through intestinal and renal clearance mitigates toxicity risk associated with long-term retention. In vivo antitumor experiments demonstrate that this bismuthene-based nanosystem is a promising and effective approach for “cold” tumor management.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, University of Chinese Academy of Sciences, Beijing 100190, People’s Republic of China

CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, People’s Republic of China

Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi’an 710069, People’s Republic of China

Research Unit of Nanoscience and Technology, Chinese Academy of Medical Sciences, Beijing 100039, People’s Republic of China

Funding

Ministry of Science and Technology of the People's Republic of China · Chinese Academy of Medical Sciences · National Natural Science Foundation of China · Natural Science Foundation of Shaanxi Province · Chinese Academy of Sciences · Key Laboratory of Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences · Chinese Society of Toxicology

References (45)

Show source-provided references
1. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
2. 10.1038/s41571-018-0142-810.1038/s41571-018-0142-8 ↗
3. 10.1038/s41573-018-0007-y10.1038/s41573-018-0007-y ↗
4. 10.1038/s41565-019-0472-410.1038/s41565-019-0472-4 ↗
5. 10.1038/s41551-016-001110.1038/s41551-016-0011 ↗
6. 10.1021/acs.nanolett.6b0199410.1021/acs.nanolett.6b01994 ↗
7. 10.1073/pnas.190692911610.1073/pnas.1906929116 ↗
8. 10.1002/adma.20160311410.1002/adma.201603114 ↗
9. 10.1016/j.biomaterials.2019.11941910.1016/j.biomaterials.2019.119419 ↗
10. 10.1021/acsnano.9b0604010.1021/acsnano.9b06040 ↗
11. 10.1021/acsnano.7b0120010.1021/acsnano.7b01200 ↗
12. 10.1002/advs.20170080510.1002/advs.201700805 ↗
13. 10.1038/nri.2017.4610.1038/nri.2017.46 ↗
14. 10.1038/s41551-017-002910.1038/s41551-017-0029 ↗
15. 10.1038/ncomms1249910.1038/ncomms12499 ↗
16. 10.1126/sciimmunol.aau658410.1126/sciimmunol.aau6584 ↗
17. 10.1021/nn506137n10.1021/nn506137n ↗
18. 10.1002/adfm.20160134110.1002/adfm.201601341 ↗
19. 10.1002/adma.20180680810.1002/adma.201806808 ↗
20. 10.1002/adfm.20130231210.1002/adfm.201302312 ↗
21. 10.1016/j.biomaterials.2019.11928210.1016/j.biomaterials.2019.119282 ↗
22. 10.1021/acsnano.6b0542710.1021/acsnano.6b05427 ↗
23. 10.1021/acsnano.6b0074510.1021/acsnano.6b00745 ↗
24. 10.1038/nnano.2014.3510.1038/nnano.2014.35 ↗
25. 10.1038/ncomms545810.1038/ncomms5458 ↗
26. 10.1002/adma.20160529910.1002/adma.201605299 ↗
27. 10.1088/1361-6528/ab767410.1088/1361-6528/ab7674 ↗
28. 10.1002/chem.20180158810.1002/chem.201801588 ↗
29. 10.1038/s41467-020-14914-910.1038/s41467-020-14914-9 ↗
30. 10.1021/acsphotonics.7b0084910.1021/acsphotonics.7b00849 ↗
31. 10.1038/mtna.2012.6310.1038/mtna.2012.63 ↗
32. 10.1016/j.ymthe.2017.11.00910.1016/j.ymthe.2017.11.009 ↗
33. 10.1016/j.ymthe.2018.04.01510.1016/j.ymthe.2018.04.015 ↗
34. 10.1038/s41467-018-05906-x10.1038/s41467-018-05906-x ↗
35. 10.1073/pnas.92.16.729710.1073/pnas.92.16.7297 ↗
36. 10.1016/j.jconrel.2010.11.00410.1016/j.jconrel.2010.11.004 ↗
37. 10.1039/D0NR00192A10.1039/D0NR00192A ↗
38. 10.1002/lpor.20170022110.1002/lpor.201700221 ↗
39. 10.1039/C8NR06797J10.1039/C8NR06797J ↗
40. 10.1021/nl900386510.1021/nl9003865 ↗
41. 10.1021/acs.nanolett.6b0415010.1021/acs.nanolett.6b04150 ↗
42. 10.1016/j.celrep.2016.03.03710.1016/j.celrep.2016.03.037 ↗
43. 10.1126/scitranslmed.aav743110.1126/scitranslmed.aav7431 ↗
44. 10.1021/jacs.6b0953810.1021/jacs.6b09538 ↗
45. 10.1038/s43018-020-0038-210.1038/s43018-020-0038-2 ↗